764
Participants
Start Date
September 24, 2018
Primary Completion Date
February 2, 2021
Study Completion Date
January 29, 2025
Baricitinib
Administered orally.
Placebo
Administered orally.
RM Pharma Specialists S.A. de C.V., Distrito Federal
Seoul National University Bundang Hospital, Seongnam
University of Rochester School of Medicine, Rochester
University of Pittsburgh Medical Center, Pittsburgh
Penn State Univ. Milton S. Hershey Medical Center, Hershey
Perelman Center for Advanced Medicine, Philadelphia
Dermatology and Skin Surgery Center, Exton
Dermatology Associates of Plymouth Meeting, Plymouth Meeting
Callender Center for Clinical Research, LLC / Research, Glenn Dale
Inha University Hospital, Jung-gu
Medical University of South Carolina, Charleston
Medaphase Inc, Newnan
Skin Care Physicians of Georgia, Macon
Park Avenue Dermatology, Orange Park
Solutions Through Advanced Research, Inc., Jacksonville
University of Miami, Miami
Instituto de Investigaciones Aplicadas a la Neurociencia A.C, Durango
Chungnam National University Hospital, Daejeon
University of Alabama at Birmingham, Birmingham
Coastal Clinical Research, Inc, Mobile
Forefront Research, Louisville
Kyung Pook National University Hospital, Daegu
OH State Univ College of Med, Gahanna
University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic Foundation, Cleveland
Clinica de Investigacion en Reumatologia y Obesidad S. C., Guadalajara
Consultorio Privado de la Dra. Villanueva, Guadalajara
Clarkston Skin Research, Clarkston
Pusan National University Hospital, Busan
Chonbuk National University Hospital, Jeonju
University of Minnesota Medical School, Minneapolis
Northwestern University, Chicago
CRI Centro Regiomontano de Investigacion S.C., Monterrey
Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey
Johnson Dermatology, Fort Smith
Modern Research Associates, Dallas
Center for Clinical Studies, Houston
Bellaire Dermatology, Bellaire
Center for Clinical Studies, Webster
Texas Dermatology and Laser Specialists, San Antonio
Dermatology Clinical Research Center of San Antonio, San Antonio
Austin Institute for Clinical Research, Pflugerville
B&B Investigaciones Medicas, SC, Mazatlán
University of Utah MidValley Dematology, Murray
Dermatology Research Associates, Los Angeles
Mosaic Dermatology, Santa Monica
California Dermatology & Clinical Research Institute, Encinitas
University Clinical Trials, Inc., San Diego
Alliance Research Centers, Irvine
University of CA, Irvine, Irvine
Stanford Health Care, Redwood City
University of California Davis-Dermatology, Sacramento
NW Dermatology & Research Center, LLC, Portland
Oregon Medical Research Center, Portland
OHSU Center for Health and Healing, Portland
Dermatology Associates, Seattle
Yale University School of Medicine, New Haven
ForCare Clinical Research, Tampa
ActivMed Practices and Research, Beverly
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
ActivMed Practices and Research, Portsmouth
Montefiore Medical Center, The Bronx
Kurume University Hospital, Kurume
Hamamatsu University School of Medicine, University Hospital, Hamamatsu
Tokyo Medical Univ. Hospital, Shinjuku-ku
Osaka City University Hospital, Osaka
Derma Norte del Bajío, S.C., Aguascalientes
Ponce School of Medicine CAIMED Center, Ponce
GCM Medical Group, PSC- Hato Rey, San Juan
Seoul National University Hospital, Seoul
Eunpyeong St. Mary's Hospital, Seoul
Konkuk University Medical Center, Seoul
Kyunghee University Hospital at Gangdong, Seoul
Chungang University Hospital, Seoul
Collaborators (1)
Incyte Corporation
INDUSTRY
Eli Lilly and Company
INDUSTRY